Institute of Cancer Research, United Kingdom — CureCurrent

Published trials97

Recruiting shown13

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLCNCT07718243 · lead sponsor · 2026-08-28

The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).NCT06636526 · lead sponsor · 2025-06-02

Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate CancerNCT07002320 · lead sponsor · 2025-04-28

Combination Study of Antibiotics With Enzalutamide (PROMIZE)NCT06126731 · lead sponsor · 2023-11-02

Microbiome Molecular CharaterisationNCT06423976 · lead sponsor · 2023-10-23

The Active Surveillance StudyNCT05810467 · lead sponsor · 2023-08-22

A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRTNCT05613023 · lead sponsor · 2022-09-09

Hypofractionated Expedited Radiotherapy for Men With localisEd proState CancerNCT04595019 · lead sponsor · 2021-07-29

PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast CancerNCT03740893 · lead sponsor · 2019-10-15

Precision Medicine in the Prostate Cancer Care PathwayNCT04763317 · lead sponsor · 2019-02-14

The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation.NCT05097274 · lead sponsor · 2015-10-15

The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and TreatmentNCT02543905 · lead sponsor · 2015-03-09

Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline MutationsNCT02705846 · lead sponsor · 2014-09-01

Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBCNCT06396754 · lead sponsor · 2026-08-01

NOT_YET_RECRUITING

The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS StudyNCT07529418 · lead sponsor · 2026-05-05

NOT_YET_RECRUITING

POTENT - Tepotinib in Combination With Pembrolizumab in NSCLCNCT05782361 · lead sponsor · 2023-05-03

ACTIVE_NOT_RECRUITING

ASTEROID: A Trial of ASTX660 in Combination With PembrolizumabNCT05082259 · lead sponsor · 2022-03-02

ACTIVE_NOT_RECRUITING

Digital Delivery of Information About Genetic Testing for Breast CancerNCT04842799 · lead sponsor · 2021-07-05

PreOperative Endocrine Therapy for Individualised Care With AbemaciclibNCT04584853 · lead sponsor · 2020-12-23

ACTIVE_NOT_RECRUITING

Abiraterone Acetate in Combination With TildrakizumabNCT04458311 · lead sponsor · 2020-12-01

Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate CancerNCT04686188 · lead sponsor · 2020-11-26

KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast CancerNCT03946202 · lead sponsor · 2020-06-16

ACTIVE_NOT_RECRUITING

Molecular Stratification Profiling Protocol in Metastatic Castration Resistant Prostate Cancer (mCRPC) - MAESTRONCT03934164 · lead sponsor · 2019-11-28

Exploring the Link Between Cancer Genetics and PPSPNCT04007861 · lead sponsor · 2019-07-01

The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.NCT03857477 · lead sponsor · 2019-03-14

ACTIVE_NOT_RECRUITING

Trial of Pembrolizumab in Metastatic Castration Resistant Prostate CancerNCT03506997 · lead sponsor · 2018-11-27

A Trial of Ipatasertib in Combination With AtezolizumabNCT03673787 · lead sponsor · 2018-08-13

ACTIVE_NOT_RECRUITING

A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer PatientsNCT03145961 · lead sponsor · 2017-12-21

Stereotactic Body Radiotherapy for the Treatment of OPDNCT03256981 · lead sponsor · 2017-11-27

Combination Study of AZD5069 and Enzalutamide.NCT03177187 · lead sponsor · 2017-11-13

The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer TreatmentNCT02955082 · lead sponsor · 2017-05-25

ACTIVE_NOT_RECRUITING

KORTUC: Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour ResponseNCT02757651 · lead sponsor · 2017-01-19

Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate CancerNCT03327662 · lead sponsor · 2017-01-11

The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) TrialNCT03182634 · lead sponsor · 2016-12-15

Imaging NSCLC Treatment Response to ImmunotherapyNCT02753569 · lead sponsor · 2016-05-31

The BARCODE 1 Pilot StudyNCT03158922 · lead sponsor · 2016-04-29

ACTIVE_NOT_RECRUITING

Quantification of Breast RadioTherapy Associated Late Toxicity Using Novel UltraSound TechniquesNCT02388230 · lead sponsor · 2015-10-01

Evaluation of Clarity Ultrasound Guidance for Prostate TherapyNCT02388308 · lead sponsor · 2015-05-15

Evolution of Resistance to Systemic Therapies in Patients With Breast CancerNCT02257775 · lead sponsor · 2015-05-11

A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPCNCT02525068 · lead sponsor · 2014-12-01

TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate CancerNCT01682772 · lead sponsor · 2012-07-01

A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate CancerNCT01685190 · lead sponsor · 2011-06-01

Assessing Treatment Response in Breast Cancer With Functional ImagingNCT02688257 · lead sponsor · 2010-09-01

Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast CancerNCT01104571 · lead sponsor · 2010-04-01

Trial of Perioperative Endocrine Therapy - Individualising CareNCT02338310 · lead sponsor · 2008-09-01

ACTIVE_NOT_RECRUITING

Radiation Therapy in Treating Women Who Have Undergone Breast Conservation Surgery and Systemic Therapy for Early Breast CancerNCT00818051 · lead sponsor · 2008-08-01

Triple Negative Breast Cancer TrialNCT00532727 · lead sponsor · 2008-01-01

MR Characterisation/Localisation of Breast CancerNCT01567137 · lead sponsor · 2007-11-01

Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast CancerNCT00299286 · lead sponsor · 2007-06-01

Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation SurgeryNCT00814567 · lead sponsor · 2007-05-03

Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By SurgeryNCT00301925 · lead sponsor · 2005-12-16

Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By SurgeryNCT00253409 · lead sponsor · 2005-05-01

The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte CancerNCT00261456 · lead sponsor · 2005-03-01

ACTIVE_NOT_RECRUITING

Radiation Therapy in Treating Women With Localized Breast CancerNCT00107497 · lead sponsor · 2004-10-05

Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Patients Who Have Undergone Radiation Therapy for CancerNCT00077090 · lead sponsor · 2004-04-01

Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or AnastrozoleNCT00077168 · lead sponsor · 2004-04-01

Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase InhibitorsNCT00253422 · lead sponsor · 2004-03-26

Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate CancerNCT00392535 · lead sponsor · 2002-10-18

Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast CancerNCT00079248 · lead sponsor · 2002-03-01

Combination Chemotherapy in Treating Women With Resected Breast CancerNCT00033683 · lead sponsor · 2001-02-01

Sponsor roles

lead sponsor64

collaborator33

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.